期刊文献+

乳腺癌组织Elf-1和MMP-2的表达及意义 被引量:1

下载PDF
导出
摘要 应用免疫组化SP法检测60例乳腺癌、13例乳腺小叶增生和15例乳腺纤维腺瘤及7例癌旁正常乳腺组织中的Elf-1和MMP-2蛋白表达情况。结果Elf-1、MMP-2在癌旁正常乳腺组织中均无表达。乳腺癌组织中Elf-1、MMP-2阳性表达率分别为83.3%、73.3%,显著高于乳腺小叶增生组织的23.1%、30.8%和乳腺纤维腺瘤组织的20.0%、20.0%,且与肿瘤大小、组织学分级、TNM分期、病理分型及淋巴结转移密切相关(P均<0.05)。乳腺癌中Elf-1与MMP-2的表达呈正相关(r=0.525,P<0.01)。认为Elf-1与MMP-2的表达水平与乳腺癌的临床病理特征有关,可作为判定乳腺癌生物学行为的参考指标。
出处 《山东医药》 CAS 北大核心 2007年第36期87-88,共2页 Shandong Medical Journal
  • 相关文献

参考文献6

  • 1Yasufumi Sato.Role of ETS Family Transcription Factors in Vascular Development and Angiogenesis[J].Cell Structure and Function,2001,26(1):19 -24.
  • 2Xu LH,Courtney B,Wei HN,et al.Critical role for the Ets transcription factor ELF-1 in the development of tumor angiogenesis[J].Blood,2006,107(8):3153 -3160.
  • 3喻钧,潘铁成,李军,魏翔,陈涛,胡敏,宋定伟,刘立刚,陈鹏.OPN、CD44v6及MMP-2在肺鳞癌、腺癌中的表达及其临床意义[J].中国肺癌杂志,2006,9(4):325-328. 被引量:15
  • 4Singh S,Barrett J,Sakata K,et al.ETS proteins and MMPs:partners in invasion and metastasis[J].Curr Drug Targets,2002,3(5):359 -367.
  • 5Lelievre E,Lionneton F,Soncin F,et al.The Ets family contains transcriptional activators and rrepressors involved in angiogenesis[J].Int J Biochem Cell Biol,2001,33(4):391 -407.
  • 6Baillat D,Begue A,Stehelin D,et al.ETS-1 Transcription Factor Binds Cooperatively to the Palindromic Head to Head ETS-binding Sites of the Stromelysin-1 Promoter by Counteracting Autoinhibition[J].J Biol Chem,2002,277(33):29386 -29398.

二级参考文献17

  • 1林全,王良兴.骨桥蛋白与血管重塑的关系研究进展[J].医学综述,2004,10(12):731-733. 被引量:8
  • 2Denhardt DT, Giachelli CM, Rittling SR. Role of osteopontin in cellular signaling and toxicant injury. Annu Rev Pharmacol Toxicol,2001,41 : 723-749.
  • 3Weber GF, Ashkar S, Glimcher MJ, et al. Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science, 1996,271(5248) : 509-512.
  • 4Haynes BF, Liao HX, Patton KL. The transmembrane hyaluronate receptor (CD44): multiple functions, multiple forms. Cancer Cells,1991,3(9) : 347 350.
  • 5Stetler Stevenson WG, Liotta LA, Kleiner DE Jr. Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J,1993,7(15) : 1434-1441.
  • 6Zhang J, Takahashi K, Takahashi F, et al. Differential osteopontin expression in lung cancer. Cancer Lett,2001,171(2) : 215-222.
  • 7Shijubo N, Uede T, Kon S, et al. Vascular endothelial growth factor and osteopontin in stage I lung adenocarcinoma. Am J Respir Crit Care Med,1999,160(4) : 1269-1273.
  • 8Pan HW, Ou YH, Peng SY, et al. Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma.Cancer,2003,98(1) : 119-127
  • 9Gao C, Guo H, Downey L, et al. Osteopontin-dependent CD44v6 expression and cell adhesion in HepG2 cells. Carcinogenesis,2003,24(12) : 1871-1878.
  • 10Hefler LA, Concin N, Mincham D, et al. The prognostic value of immunohistochemically detected CD44v3 and CD44v6 expression in patients with surgically staged vulvar carcinoma: a multicenter study. Cancer,2002,94(1) : 125-130.

共引文献14

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部